Kasper Drimer Berg1, Davide Soldini2, Maria Jung3, Dimo Dietrich3, Carsten Stephan4, Klaus Jung5, Manfred Dietel6, Ben Vainer7, Glen Kristiansen8. 1. Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 2. Institute of Surgical Pathology, University Hospital Zurich (USZ), Zurich, Switzerland. 3. Institute of Pathology, University Hospital Bonn (UKB), Sigmund-Freud-Str. 25, 53127, Bonn, Germany. 4. Department of Urology, Charité University Hospital, Berlin, Germany. 5. Berlin Institute for Urologic Research, Berlin, Germany. 6. Institute of Pathology, Charité University Hospital, Berlin, Germany. 7. Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 8. Institute of Pathology, University Hospital Bonn (UKB), Sigmund-Freud-Str. 25, 53127, Bonn, Germany. glen.kristiansen@ukb.uni-bonn.de.
Abstract
BACKGROUND: Transient receptor potential cation channel, subfamily M, member 4 (TRPM4) messenger RNA (mRNA) has been shown to be upregulated in prostate cancer (PCa) and might be a new promising tissue biomarker. We evaluated TRPM4 protein expression and correlated the expression level with biochemical recurrence (BR) following radical prostatectomy (RP). MATERIAL AND METHODS: The study included 614 patients who had undergone RP. TRPM4 immunohistochemical staining was performed on samples of benign tissue, tissue containing PIN glands and PCa tissue using a commercially available polyclonal antibody. Staining intensity was recorded by two independent observers using a four-tired semi-quantitative grading system (0, 1+, 2+, 3+) converted into H-scores. Interobserver agreement was calculated by linear weighted kappa statistics. The association between staining intensity and BR was analysed using the Kaplan-Meier estimator and uni- and multiple Cox proportional hazard regression models. RESULTS: Significantly higher staining intensity was found in PCa glands compared to benign glands (p < 0.001). The concordance rate in TRPM4 staining intensities for benign, PIN and PCa tissue ranged from 86.0 to 91.5 %, corresponding to linear weighted kappa values of 0.566-0.789. After adjusting for patient and tumour characteristics, patients with a higher staining intensity in PCa glands compared to matched benign glands and an H-score equal to or above the median had an increased risk of BR (HR 1.79-2.62; p = 0.01-0.03 for the two observers) when compared to patients with a lower staining intensity. CONCLUSIONS: TRPM4 protein expression is widely expressed in benign and cancerous prostate tissue, with highest staining intensities found in PCa. Overexpression of TRPM4 in PCa (combination of high staining intensity and a high H-score) is associated with increased risk of BR after RP.
BACKGROUND:Transient receptor potential cation channel, subfamily M, member 4 (TRPM4) messenger RNA (mRNA) has been shown to be upregulated in prostate cancer (PCa) and might be a new promising tissue biomarker. We evaluated TRPM4 protein expression and correlated the expression level with biochemical recurrence (BR) following radical prostatectomy (RP). MATERIAL AND METHODS: The study included 614 patients who had undergone RP. TRPM4 immunohistochemical staining was performed on samples of benign tissue, tissue containing PIN glands and PCa tissue using a commercially available polyclonal antibody. Staining intensity was recorded by two independent observers using a four-tired semi-quantitative grading system (0, 1+, 2+, 3+) converted into H-scores. Interobserver agreement was calculated by linear weighted kappa statistics. The association between staining intensity and BR was analysed using the Kaplan-Meier estimator and uni- and multiple Cox proportional hazard regression models. RESULTS: Significantly higher staining intensity was found in PCa glands compared to benign glands (p < 0.001). The concordance rate in TRPM4 staining intensities for benign, PIN and PCa tissue ranged from 86.0 to 91.5 %, corresponding to linear weighted kappa values of 0.566-0.789. After adjusting for patient and tumour characteristics, patients with a higher staining intensity in PCa glands compared to matched benign glands and an H-score equal to or above the median had an increased risk of BR (HR 1.79-2.62; p = 0.01-0.03 for the two observers) when compared to patients with a lower staining intensity. CONCLUSIONS:TRPM4 protein expression is widely expressed in benign and cancerous prostate tissue, with highest staining intensities found in PCa. Overexpression of TRPM4 in PCa (combination of high staining intensity and a high H-score) is associated with increased risk of BR after RP.
Authors: Pierre Launay; Andrea Fleig; Anne Laure Perraud; Andrew M Scharenberg; Reinhold Penner; Jean Pierre Kinet Journal: Cell Date: 2002-05-03 Impact factor: 41.582
Authors: K Vanoverberghe; F Vanden Abeele; P Mariot; G Lepage; M Roudbaraki; J L Bonnal; B Mauroy; Y Shuba; R Skryma; N Prevarskaya Journal: Cell Death Differ Date: 2004-03 Impact factor: 15.828
Authors: Jennifer R Rider; Fredrik Sandin; Ove Andrén; Peter Wiklund; Jonas Hugosson; Pär Stattin Journal: Eur Urol Date: 2012-08-10 Impact factor: 20.096
Authors: Andrea Kiessling; Susanne Füssel; Marc Schmitz; Stefan Stevanovic; Axel Meye; Bernd Weigle; Ulrich Klenk; Manfred P Wirth; Ernst P Rieber Journal: Prostate Date: 2003-09-01 Impact factor: 4.104
Authors: Susan M Henshall; Daniel E H Afar; Jordan Hiller; Lisa G Horvath; David I Quinn; Krishan K Rasiah; Kurt Gish; Dorian Willhite; James G Kench; Margaret Gardiner-Garden; Phillip D Stricker; Howard I Scher; John J Grygiel; David B Agus; David H Mack; Robert L Sutherland Journal: Cancer Res Date: 2003-07-15 Impact factor: 12.701
Authors: G Kristiansen; F R Fritzsche; K Wassermann; C Jäger; A Tölls; M Lein; C Stephan; K Jung; C Pilarsky; M Dietel; H Moch Journal: Br J Cancer Date: 2008-09-16 Impact factor: 7.640
Authors: Alfredo I Sagredo; Eduardo A Sagredo; Claudio Cappelli; Pablo Báez; Rodrigo E Andaur; Constanza Blanco; Julio C Tapia; César Echeverría; Oscar Cerda; Andrés Stutzin; Felipe Simon; Katherine Marcelain; Ricardo Armisén Journal: Mol Oncol Date: 2017-12-30 Impact factor: 6.603
Authors: Sven Kappel; Paulina Stokłosa; Barbara Hauert; Daniela Ross-Kaschitza; Anna Borgström; Roland Baur; José A Galván; Inti Zlobec; Christine Peinelt Journal: Mol Oncol Date: 2019-09-12 Impact factor: 6.603
Authors: María Paz Saldías; Diego Maureira; Octavio Orellana-Serradell; Ian Silva; Boris Lavanderos; Pablo Cruz; Camila Torres; Mónica Cáceres; Oscar Cerda Journal: Front Oncol Date: 2021-06-10 Impact factor: 6.244